Loading...
•
Mar 30
Teleflex Q1 2025 Earnings Report
Reported First Quarter 2025 Financial Results
Key Takeaways
Teleflex reported a decrease in revenue for the first quarter of 2025 compared to the prior year, driven by declines in the EMEA and Asia segments and the OEM product category. Despite this, the company saw growth in Vascular Access, Interventional, Surgical, and Other product categories. GAAP EPS increased significantly while Adjusted Diluted EPS decreased.
Revenues of $700.7 million, down 5.0% compared to the prior year period.
GAAP diluted EPS from continuing operations was $2.07, a significant increase from $0.33 in the prior year period.
Adjusted diluted EPS from continuing operations was $2.91, compared to $3.21 in the prior year period.
The company is exploring strategic options for the separation of Teleflex into two independent publicly traded companies.
Teleflex
Teleflex
Teleflex Revenue by Segment
Teleflex Revenue by Geographic Location
Revenue by Segment
Americas Segment Revenue
CapyFin.comEMEA Segment Revenue
CapyFin.comAsia Segment Revenue
CapyFin.comRevenue by Geographic Location
Vascular Access Revenue
CapyFin.comInterventional Revenue
CapyFin.comAnesthesia Revenue
CapyFin.comSurgical Revenue
CapyFin.comInterventional Urology Revenue
CapyFin.comOEM Revenue
CapyFin.comOther Revenue
CapyFin.com Forward Guidance
Teleflex is raising its full year 2025 GAAP revenue growth guidance and maintaining its adjusted constant currency revenue growth guidance. The company is lowering its GAAP and adjusted diluted EPS guidance due to the impact of tariffs and separation/acquisition-related expenses, partially offset by share repurchases and expense control.
Positive Outlook
- Raising full year 2025 GAAP revenue growth guidance range to 1.28% to 2.28%.
- Maintaining adjusted constant currency revenue growth guidance range of 1.00% to 2.00%.
- Completed a $300 million accelerated share repurchase.
- Evaluating strategies to mitigate exposure to tariffs.
- Actively exploring options for the NewCo separation, including a potential sale, to maximize shareholder value.
Challenges Ahead
- Lowering GAAP EPS from continuing operations guidance range to $6.51 to $6.91 due to tariffs and separation/acquisition-related expenses.
- Lowering adjusted diluted EPS from continuing operations guidance range to $13.20 to $13.60 due to tariffs.
- Expect an impact from tariffs of approximately $55 million in 2025.
- Separation and acquisition-related expenses are impacting GAAP EPS guidance.
- Adjusted diluted EPS guidance represents a decrease of 5.8% to 2.9% year-over-year.
Revenue & Expenses
Visualization of income flow from segment revenue to net income